Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis.
about
Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial.Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis.Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Delayed Sputum Conversion in TB-HIV Co-Infected Patients with Low Isoniazid and Rifampicin Concentrations.The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugsThe importance of clinical pharmacokinetic-pharmacodynamic studies in unraveling the determinants of early and late tuberculosis outcomes
P2860
Q35867681-5007DBAF-1077-4CFE-AE57-6DDA2CD2803AQ38763608-E222F39A-1E0E-46D3-B9D1-9907605AF697Q38865905-53936DFB-256B-41BF-9B93-F66CA16A305BQ47332682-F322F924-0675-49EE-9D98-7EF02CDB7C3EQ52669182-E1404F2F-6843-4DCD-96C2-69A09A4C8F34Q56912878-E2A25F10-A61C-4C83-94BC-9242BFF7FB75Q57152709-31CC605C-1FE3-4F5F-8CE8-39BC466F0B4F
P2860
Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacokinetic Modeling and O ...... in Patients with Tuberculosis.
@ast
Pharmacokinetic Modeling and O ...... in Patients with Tuberculosis.
@en
type
label
Pharmacokinetic Modeling and O ...... in Patients with Tuberculosis.
@ast
Pharmacokinetic Modeling and O ...... in Patients with Tuberculosis.
@en
prefLabel
Pharmacokinetic Modeling and O ...... in Patients with Tuberculosis.
@ast
Pharmacokinetic Modeling and O ...... in Patients with Tuberculosis.
@en
P2093
P2860
P356
P1476
Pharmacokinetic Modeling and O ...... in Patients with Tuberculosis.
@en
P2093
Arthur de Jager
Jan-Willem C Alffenaar
Johannes H Proost
Jos G W Kosterink
Leonie W Mulder
Marieke G G Sturkenboom
Richard van Altena
Rob E Aarnoutse
Tjip S van der Werf
Wiel C M de Lange
P2860
P304
P356
10.1128/AAC.00756-15
P407
P577
2015-06-08T00:00:00Z